ANAVEX New Website - Untitled Page.png

News, Events and Updates

Search
Anavex Life Sciences Announces First Participant Enrolled in Phase 1 Study of ANAVEX®3-71 (AF710B)
  • Jul 6, 2020

Anavex Life Sciences Announces First Participant Enrolled in Phase 1 Study of ANAVEX®3-71 (AF710B)

Anavex Life Sciences Announces Initiation of First-in-Human Phase 1 Study of ANAVEX®3-71 (AF710B)
  • May 21, 2020

Anavex Life Sciences Announces Initiation of First-in-Human Phase 1 Study of ANAVEX®3-71 (AF710B)

Stay Connected

Follow us on social media

  • Twitter
  • LinkedIn
  • Instagram
  • Facebook
Newsroom
Webcast Library
Contact Us
Back to Newsroom

Quick Links

Home

Therapeutic Candidates

Investors

News

Patients & Carers

Contact Us

Resources

About Us

SIGMACEPTOR™ 

Corporate Presentation

Forward-Looking Statements

Legal Notice

Privacy Policy

New Logo white .png

Join our mailing list

Thank you for subscribing!

ANAVEX® is a trademark of Anavex Life Sciences Corp. © 2007-2022. All Rights Reserved.